Page 8 - CIMA SCS Workbook November 2018 - Day 2 Tasks
P. 8

CIMA NOVEMBER 2018 – STRATEGIC CASE STUDY

               TASK

               Prepare an email in response to Dirk Lepain as requested       (Time allowed: 60 minutes)

               (Refer to the reference materials below)

               Reference Materials – email to Dirk Lepain from Richard Stilton


               Email

               To:         Dirk Lepain, CEO, Novak Pharmaceuticals
               From:       Richard Stilton, Stilton & Associates
               Subject:    Consultancy advice re PRA

               I hope all is well with you; you have certainly achieved great things since our days at Cronland
               Central University together, and I have followed your career in the pharmaceutical industry with
               interest.

               I have had various roles since graduation, all linked with the government (you may remember I
               studied politics at university) and in particular the Ministry for Health. Three years ago I decided
               that I wanted to work for myself, and so set up a consultancy whereby I could use my links with
               political decision-makers to the benefit of other organisations. I have particularly strong
               relationships with 2 members of the Drug Approval Board at the PRA, the committee that
               ultimately makes the decision on whether to approve new drugs for purchase by the Ministry of
               Health in Cronland.

               I would welcome the chance to meet with you to discuss how our businesses might work
               together, about our fee structure and an expense budget for talking to my contacts so as to
               maximise the chances of Novak products gaining the necessary regulatory approval. It would also
               be a great opportunity to discuss old times!

               I look forward to hearing from you

               Richard




























               24                                                                  KAPLAN PUBLISHING
   3   4   5   6   7   8   9   10   11   12   13